# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-029951
Filing Date
2024-03-12
Accepted
2024-03-12 16:15:30
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | hrtx-20231231.htm iXBRL | 10-K | 2447882
2 | EX-23.1 | hrtx-ex23_1.htm | EX-23.1 | 5061
3 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 15234
4 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 15171
5 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 9491
6 | EX-97.1 | hrtx-ex97_1.htm | EX-97.1 | 13852
| Complete submission text file | 0000950170-24-029951.txt |  | 10567119

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20231231.xsd | EX-101.SCH | 1450868
78 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20231231_htm.xml | XML | 2017380

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 24742255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)